Trial intelligence / Profile preview

Tripterygium wilfordii Hook F vs acitretin in moderate to severe psoriasis vulgaris

ChiCTR-IPR-17010494Phase 4Recruiting

Sponsor
Peking Union Medical College Hospital
Start
Jan 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in plaque psoriasis comparing Tripterygium wilfordii Hook F monotherapy, Acitretin monotherapy and Tripterygium wilfordii Hook F + acitretin combination (3 arms). Started Jan 2016; status: recruiting.

02

Drugs

Tripterygium wilfordiiacitretin
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on ChiCTR-IPR-17010494.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-17010494.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call